Press-release for stocks for glaxosmithkline plc for bmy

| -4.25% | O: 0.99% H: 0.0% C: 0.0%
NVSEF | News | $95.11 490

| -0.6% | O: -100.0% H: NaN% C: Infinity%
NVS | News | $98.12 3.15% 1.1M

| -1.16% | O: 0.52% H: 0.0% C: 0.0%
JNJ | News | $148.24 -0.59% 1.6M

| -4.47% | O: 1.32% H: 0.0% C: 0.0%
GSK | News | $40.865 0.68% 320K

| -5.58% | O: 0.02% H: 0.51% C: -0.3%
LLY | News | $739.11 1.06% 320K

| -6.02% | O: 0.28% H: 1.71% C: -0.3%
BMY | $49.28 0.29% 800K

| -7.72% | O: 0.26% H: 2.03% C: 1.57%
AMGN | News | $272.245 0.12% 220K

| -5.03% | O: 0.54% H: 0.0% C: 0.0%
antibody research global

Pharmaceutical Market In Canada size is set to grow by USD 8.73 bn from 2024-2028, Abbott Laboratories, AbbVie Inc. & Amgen Inc., and more to emerge as Some of the Key Vendors, Technavio
Published: 2024-03-27 (Crawled : 22:00) - prnewswire.com
GLAXF | News | $20.305 630

| -4.25% | O: 0.99% H: 0.0% C: 0.0%
SNYNF | News | $92.7 600K

| -7.02% | O: -1.17% H: 0.0% C: -0.89%
AZNCF | News | $138.73 3.7K

| 2.99% | O: 0.89% H: 0.78% C: 0.78%
NVSEF | News | $95.11 490

| -0.6% | O: -100.0% H: NaN% C: Infinity%
NVS | News | $98.12 3.15% 1.1M

| -1.16% | O: 0.52% H: 0.0% C: 0.0%
GSK | News | $40.865 0.68% 320K

| -5.58% | O: 0.02% H: 0.51% C: -0.3%
BMY | $49.28 0.29% 800K

| -7.72% | O: 0.26% H: 2.03% C: 1.57%
ABBV | News | $169.22 0.79% 370K

| -6.91% | O: 0.36% H: 0.72% C: 0.61%
ABT | News | $107.51 0.41% 310K

| -4.46% | O: 1.04% H: 0.0% C: 0.0%
SNY | News | $47.375 0.48% 300K

| -6.93% | O: -0.96% H: 0.0% C: 0.0%
AZN | News | $70.47 0.49% 990K

| 2.74% | O: -0.12% H: 0.25% C: -0.63%
AMGN | News | $272.245 0.12% 220K

| -5.03% | O: 0.54% H: 0.0% C: 0.0%
abbvie set canada key market

Urinary Tract Infection Treatment Market Projected to Reach US$ 10.73 Billion by 2030: Telemedicine Integration Revolutionizes UTI Care, Self-Care Products Gain Momentum
Published: 2024-02-29 (Crawled : 20:00) - prnewswire.com
GLAXF | News | $20.305 630

| -3.29% | O: -2.33% H: 3.68% C: 2.44%
NVSEF | News | $95.11 490

| -5.92% | O: 0.89% H: 0.0% C: 0.0%
NVS | News | $98.12 3.15% 1.1M

| -6.14% | O: 1.03% H: 0.14% C: 0.05%
JNJ | News | $148.24 -0.59% 1.6M

| -7.6% | O: 0.28% H: 0.0% C: 0.0%
GSK | News | $40.865 0.68% 320K

| -3.13% | O: 0.26% H: 0.18% C: 0.05%
BMY | $49.28 0.29% 800K

| -3.17% | O: 0.37% H: 0.27% C: -0.1%
integration reach momentum infection treatment market

Non-Small Cell Lung Cancer (NSCLC) Market to Reach $29.95 Billion by 2028, Fueled by Advances in Therapy and Diagnostics
Published: 2024-02-22 (Crawled : 01:00) - prnewswire.com
GLAXF | News | $20.305 630

| -5.41% | O: 0.14% H: 0.0% C: -0.0%
SNYNF | News | $92.7 600K

| -3.13% | O: 0.26% H: 1.36% C: 1.36%
AZNCF | News | $138.73 3.7K

| 9.24% | O: -0.85% H: 1.12% C: 0.43%
NVSEF | News | $95.11 490

| -6.69% | O: 0.92% H: 0.0% C: 0.0%
UCBJY | $64.93 6.2K

| 27.56% | O: 1.46% H: 0.44% C: 0.44%
ALPMY | News | $9.53 690K

| -14.3% | O: -0.27% H: 0.0% C: -1.17%
TAK | News | $13.35 -0.08% 230K

| -9.36% | O: -0.2% H: 0.14% C: -0.48%
NVS | News | $98.12 3.15% 1.1M

| -7.6% | O: -0.06% H: 0.46% C: 0.29%
GSK | News | $40.865 0.68% 320K

| -3.22% | O: -0.69% H: 1.42% C: 1.22%
LLY | News | $739.11 1.06% 320K

| -1.95% | O: 2.37% H: 1.51% C: 0.79%
BMY | $49.28 0.29% 800K

| -3.48% | O: -0.65% H: 1.63% C: 1.48%
ABBV | News | $169.22 0.79% 370K

| -4.79% | O: -0.88% H: 1.46% C: 1.13%
SNY | News | $47.375 0.48% 300K

| -1.81% | O: 1.67% H: 0.0% C: 0.0%
AZN | News | $70.47 0.49% 990K

| 7.74% | O: -2.81% H: 2.08% C: 1.38%
AMGN | News | $272.245 0.12% 220K

| -4.07% | O: -0.35% H: 1.15% C: 0.96%
lung reach cancer cell diagnostics therapy market

Checkpoint Inhibitors Market Forecast Reveals Impressive Growth With Focus on Novel Therapies and Regional Expansion
Published: 2024-02-12 (Crawled : 23:00) - prnewswire.com
GLAXF | News | $20.305 630

| -1.11% | O: 3.52% H: 0.0% C: -1.18%
AZNCF | News | $138.73 3.7K

| 14.97% | O: 0.06% H: 2.34% C: 2.29%
ALPMY | News | $9.53 690K

| -11.92% | O: 0.37% H: 0.74% C: 0.28%
TAK | News | $13.35 -0.08% 230K

| -6.64% | O: 0.14% H: 0.35% C: 0.07%
NVS | News | $98.12 3.15% 1.1M

| -5.73% | O: -0.34% H: 0.23% C: -1.13%
JNJ | News | $148.24 -0.59% 1.6M

| -4.78% | O: 0.7% H: 0.0% C: 0.0%
GSK | News | $40.865 0.68% 320K

| -1.17% | O: 1.22% H: 0.07% C: -0.43%
LLY | News | $739.11 1.06% 320K

| -0.8% | O: -0.96% H: 1.75% C: 1.75%
BMY | $49.28 0.29% 800K

| -1.23% | O: -0.18% H: 0.48% C: -1.91%
ABBV | News | $169.22 0.79% 370K

| -2.99% | O: 0.8% H: 0.0% C: 0.0%
ZLAB | $15.325 2.24% 87K

| -17.68% | O: -1.15% H: 1.03% C: -1.5%
VRTX | $404.015 1.02% 120K

| -5.01% | O: -0.28% H: 0.49% C: -0.32%
SNY | News | $47.375 0.48% 300K

| 0.16% | O: -0.06% H: 0.0% C: 0.0%
IPHA | $2.425 530

| -6.2% | O: -3.1% H: 1.2% C: -0.8%
INCY | $51.475 -0.86% 230K

| -10.24% | O: 3.8% H: 1.1% C: -1.17%
BIIB | $194.76 0.34% 110K

| -20.69% | O: -3.72% H: 0.58% C: -3.82%
AZN | News | $70.47 0.49% 990K

| 14.2% | O: -0.26% H: 0.73% C: -0.36%
ARGX | $371.055 0.63% 58K

| -6.1% | O: -2.3% H: 1.65% C: 0.83%
AMGN | News | $272.245 0.12% 220K

| -7.65% | O: 0.06% H: 0.31% C: -1.4%
expansion growth market

Antibacterial Drugs Market Report 2024-2034, Featuring Profiles of AbbVie, AstraZeneca, Bayer, Bristol-Myers Squibb, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer & Sanofi
Published: 2024-01-26 (Crawled : 16:00) - prnewswire.com
GLAXF | News | $20.305 630

| 2.97% | O: -1.67% H: 0.0% C: 0.0%
SNYNF | News | $92.7 600K

| -6.6% | O: 1.8% H: 0.0% C: -1.82%
NVS | News | $98.12 3.15% 1.1M

| -11.42% | O: 0.29% H: 0.15% C: -0.13%
JNJ | News | $148.24 -0.59% 1.6M

| -6.27% | O: 0.8% H: 0.0% C: 0.0%
GSK | News | $40.865 0.68% 320K

| 4.51% | O: 1.36% H: 0.23% C: -0.76%
BMY | $49.28 0.29% 800K

| -0.95% | O: 0.71% H: 0.48% C: -0.52%
ABBV | News | $169.22 0.79% 370K

| 2.43% | O: 0.85% H: 0.0% C: 0.0%
SNY | News | $47.375 0.48% 300K

| -7.26% | O: 0.5% H: 0.0% C: 0.0%
report antibacterial sanofi market

Global Urinary Tract Infection (UTI) Treatment Market is expected to Reach US$ 13,617.4 million by 2034, rising at a 1.9% CAGR- FMI Study
Published: 2024-01-22 (Crawled : 19:00) - prnewswire.com
GLAXF | News | $20.305 630

| 1.0% | O: -2.34% H: 0.43% C: 0.43%
JNJ | News | $148.24 -0.59% 1.6M

| -7.93% | O: -1.11% H: 0.0% C: 0.0%
GSK | News | $40.865 0.68% 320K

| 2.68% | O: -0.76% H: 0.38% C: 0.13%
BMY | $49.28 0.29% 800K

| -0.87% | O: 0.22% H: 1.49% C: 0.89%
expected million reach infection treatment global study market

Conquering Challenges in the Solid Tumor Market: Your Guide to FDA-EMA Indications, Regulatory Compliance, and Market Access Excellence | Disease Landscape Insights
Published: 2023-09-21 (Crawled : 15:30) - prnewswire.com
AZNCF | News | $138.73 3.7K

| 1.75% | O: -1.13% H: 0.0% C: -0.63%
JNJ | News | $148.24 -0.59% 1.6M

| -7.8% | O: 0.52% H: 0.57% C: -0.56%
GSK | News | $40.865 0.68% 320K

| 6.62% | O: -0.5% H: 0.26% C: -0.69%
LLY | News | $739.11 1.06% 320K

| 27.46% | O: -1.47% H: 0.0% C: 0.0%
BMY | $49.28 0.29% 800K

| -16.4% | O: -0.37% H: 1.54% C: 0.89%
ABBV | News | $169.22 0.79% 370K

| 9.2% | O: -0.04% H: 0.76% C: -0.16%
SNY | News | $47.375 0.48% 300K

| -16.49% | O: -1.16% H: 0.0% C: 0.0%
AZN | News | $70.47 0.49% 990K

| 3.19% | O: 0.19% H: 0.03% C: -1.57%
AMGN | News | $272.245 0.12% 220K

| 0.17% | O: 0.22% H: 0.15% C: -0.98%
disease tumor market

Myasthenia Gravis Treatment Market to Grow Exponentially by 2029 | Brandessence Market Research
Published: 2023-09-18 (Crawled : 14:00) - prnewswire.com
GLAXF | News | $20.305 630

| 9.73% | O: 2.7% H: 0.0% C: -5.11%
GSK | News | $40.865 0.68% 320K

| 8.44% | O: 0.72% H: 0.13% C: -0.93%
BMY | $49.28 0.29% 800K

| -16.75% | O: 0.02% H: 0.18% C: -0.78%
ABBV | News | $169.22 0.79% 370K

| 9.98% | O: 0.33% H: 0.0% C: 0.0%
BIIB | $194.76 0.34% 110K

| -23.82% | O: 0.06% H: 0.44% C: -0.64%
treatment research market

Global Orphan Drugs Market Analysis Report 2023: A 229.71 Billion Market by 2026 - Therapeutic Versatility and the Impacts on Oncology, Hematology, and More
Published: 2023-09-15 (Crawled : 16:00) - prnewswire.com
GLAXF | News | $20.305 630

| 13.92% | O: 3.82% H: 0.0% C: 0.0%
NVSEF | News | $95.11 490

| 12.22% | O: 0.79% H: 0.0% C: 0.0%
NVS | News | $98.12 3.15% 1.1M

| -6.93% | O: 1.51% H: 0.26% C: -0.72%
JNJ | News | $148.24 -0.59% 1.6M

| -8.93% | O: 0.15% H: 0.51% C: -1.54%
GSK | News | $40.865 0.68% 320K

| 8.56% | O: 0.83% H: 0.27% C: -0.72%
LLY | News | $739.11 1.06% 320K

| 23.62% | O: 0.08% H: 0.0% C: 0.0%
BMY | $49.28 0.29% 800K

| -17.4% | O: -0.08% H: 0.65% C: -0.69%
ABBV | News | $169.22 0.79% 370K

| 9.27% | O: -0.64% H: 0.0% C: 0.0%
report global market

Oral Antiviral Market Report 2023: Demand for Novel Therapeutics Boosts Opportunities
Published: 2023-09-09 (Crawled : 04:20) - prnewswire.com
VTRS | News A | $11.3 0.44% 570K

| Email alert Add to watchlist
GSK | News | $40.865 0.68% 320K

| Email alert Add to watchlist
BMY | $49.28 0.29% 800K

| Email alert Add to watchlist
GILD | $67.29 0.51% 730K

| Email alert Add to watchlist
ABBV | News | $169.22 0.79% 370K

| Email alert Add to watchlist
GLAXF | News | $20.305 630

| Email alert Add to watchlist
TEVJF | News | $12.37 -24.22% 380

| Email alert Add to watchlist
JNJ | News | $148.24 -0.59% 1.6M

| Email alert Add to watchlist
report antiviral therapeutics market

Global Cancer Therapies Strategic Business Report 2023: Industry Focuses on New Approaches to Treat Cancer
Published: 2023-06-27 (Crawled : 01:00) - prnewswire.com
GLAXF | News | $20.305 630

| 11.75% | O: -1.1% H: 0.0% C: 0.0%
TAK | News | $13.35 -0.08% 230K

| -15.28% | O: -0.95% H: 0.19% C: -0.32%
PFE | News A | $26.32 0.23% 4.4M

| -28.82% | O: 0.19% H: 0.11% C: -1.46%
NVS | News | $98.12 3.15% 1.1M

| -4.76% | O: -0.01% H: 0.16% C: -0.32%
JNJ | News | $148.24 -0.59% 1.6M

| -8.87% | O: 0.03% H: 0.12% C: -0.24%
GSK | News | $40.865 0.68% 320K

| 11.91% | O: -0.91% H: 0.56% C: -0.5%
LLY | News | $739.11 1.06% 320K

| 61.53% | O: 2.15% H: 1.18% C: 0.43%
BMY | $49.28 0.29% 800K

| -24.15% | O: -0.06% H: 0.46% C: 0.0%
AZN | News | $70.47 0.49% 990K

| -2.23% | O: -0.21% H: 0.42% C: 0.13%
report business cancer treat global

Global Peptide Therapeutics Market Report 2023: Increasing Prevalence of Cancer and Metabolic Disorders Drives Growth
Published: 2023-06-08 (Crawled : 02:00) - prnewswire.com
AZNCF | News | $138.73 3.7K

| -5.56% | O: 0.07% H: 0.0% C: -1.7%
NVSEF | News | $95.11 490

| 16.05% | O: 1.32% H: 0.0% C: -0.62%
TAK | News | $13.35 -0.08% 230K

| -16.97% | O: -0.62% H: 0.88% C: 0.81%
NVS | News | $98.12 3.15% 1.1M

| -3.79% | O: 1.26% H: 1.08% C: 0.91%
GSK | News | $40.865 0.68% 320K

| 18.13% | O: 0.41% H: 0.68% C: 0.64%
LLY | News | $739.11 1.06% 320K

| 67.59% | O: -0.11% H: 2.66% C: 2.24%
BMY | $49.28 0.29% 800K

| -24.59% | O: 0.28% H: 0.42% C: -0.05%
BNTX | News | $89.07 1.2% 44K

| -19.56% | O: 0.39% H: 0.15% C: -0.79%
AZN | News | $70.47 0.49% 990K

| -4.34% | O: -0.23% H: 1.83% C: 1.52%
AMGN | News | $272.245 0.12% 220K

| 22.9% | O: 0.0% H: 0.28% C: -0.23%
metabolic report cancer global therapeutics growth market

Global HIV Treatment Market Report 2023: Advances in Gene Therapy Present Significant Opportunities for Sector Growth
Published: 2023-05-31 (Crawled : 00:00) - prnewswire.com
GLAXF | News | $20.305 630

| 21.63% | O: -0.24% H: 2.1% C: 2.1%
VTRS | News A | $11.3 0.44% 570K

| 22.95% | O: 0.0% H: 0.66% C: 0.33%
TEVA | $12.895 0.12% 1.2M

| 78.89% | O: 0.42% H: 0.83% C: -0.41%
JNJ | News | $148.24 -0.59% 1.6M

| -3.83% | O: -0.34% H: 0.32% C: 0.0%
GSK | News | $40.865 0.68% 320K

| 20.8% | O: -0.24% H: 1.43% C: 0.84%
BMY | $49.28 0.29% 800K

| -23.74% | O: 0.03% H: 0.41% C: 0.34%
ABBV | News | $169.22 0.79% 370K

| 21.69% | O: -1.96% H: 0.0% C: -1.35%
ABT | News | $107.51 0.41% 310K

| 4.97% | O: -0.09% H: 0.97% C: 0.89%
GILD | $67.29 0.51% 730K

| -12.98% | O: 0.78% H: 0.0% C: -1.72%
report treatment global hiv therapy growth market

Global API and Pharmaceutical Excipients Market Report 2022-2029 Featuring Catalent, Divis Labs, Euroapi Lonza, Pfizer, Samsung Biologics, Teva, Thermo Fisher Scientific, Wuxi Apptec, & Wuxi Biologics
Published: 2023-03-06 (Crawled : 20:00) - prnewswire.com
CMXHF | $176.0 50

| -10.35% | O: -0.86% H: 0.33% C: 0.33%
CSLLY | $89.17 54K

| -9.97% | O: -0.02% H: 0.54% C: -1.7%
AZNCF | News | $138.73 3.7K

| 6.55% | O: -2.57% H: 1.62% C: 1.62%
TMO | News | $572.645 4.43% 800K

| -1.82% | O: 0.41% H: 0.39% C: -2.14%
TEVA | $12.895 0.12% 1.2M

| 29.97% | O: -1.21% H: 0.43% C: -3.58%
TAK | News | $13.35 -0.08% 230K

| -14.58% | O: 0.83% H: 0.06% C: -1.2%
PRGO | $30.48 1.4% 120K

| -18.67% | O: 0.76% H: 1.91% C: 1.26%
GSK | News | $40.865 0.68% 320K

| 17.82% | O: 0.32% H: 0.17% C: -1.53%
LLY | News | $739.11 1.06% 320K

| 129.29% | O: 0.01% H: 0.42% C: -2.62%
CTLT | $56.005 -0.08% 220K

| -21.43% | O: 0.11% H: 0.53% C: -5.05%
BMY | $49.28 0.29% 800K

| -28.68% | O: 0.41% H: 0.04% C: -1.71%
ALB | News | $115.01 2.42% 280K

Process Industries

| -56.29% | O: -0.95% H: 1.02% C: -2.19%
ABBV | News | $169.22 0.79% 370K

| 8.12% | O: 0.19% H: 0.06% C: -1.7%
SNY | News | $47.375 0.48% 300K

| -3.05% | O: 0.65% H: 0.0% C: 0.0%
GILD | $67.29 0.51% 730K

| -17.46% | O: 0.23% H: 0.0% C: -1.25%
BIIB | $194.76 0.34% 110K

| -28.17% | O: 0.28% H: 0.0% C: -2.26%
AZN | News | $70.47 0.49% 990K

| 8.63% | O: 0.9% H: 0.28% C: -1.3%
global report market

Global Personalized Medicines Strategic Market Report 2023: Market to Surpass $740 Billion by 2030 - Genomics to Dictate Advancement of Personalized Medicines
Published: 2023-02-17 (Crawled : 04:00) - prnewswire.com
TMO | News | $572.645 4.43% 800K

| -1.65% | O: -0.84% H: 1.55% C: 1.23%
NVS | News | $98.12 3.15% 1.1M

| 10.25% | O: -0.24% H: 1.61% C: 1.52%
GSK | News | $40.865 0.68% 320K

| 15.51% | O: 0.54% H: 1.6% C: 1.56%
BMY | $49.28 0.29% 800K

| -30.64% | O: -0.32% H: 1.59% C: 0.69%
HOLX | $77.055 1.1% 150K

| -7.75% | O: 0.1% H: 0.31% C: 0.04%
global report genomics market

Myelofibrosis Treatment Market to Reach $1.16 Billion, Globally, by 2031 at 4.0% CAGR: Allied Market Research
Published: 2023-02-06 (Crawled : 12:00) - prnewswire.com
GLAXF | News | $20.305 630

| 16.73% | O: 2.88% H: 1.17% C: -2.24%
GSK | News | $40.865 0.68% 320K

| 16.54% | O: 1.64% H: 0.24% C: -0.17%
BMY | $49.28 0.29% 800K

| -34.0% | O: 0.0% H: 0.98% C: 0.11%
AMRX | $5.435 1.21% 110K

| 120.99% | O: 0.0% H: 6.58% C: 4.53%
ABBV | News | $169.22 0.79% 370K

| 15.63% | O: 0.37% H: 0.4% C: -0.49%
INCY | $51.475 -0.86% 230K

| -37.9% | O: 0.0% H: 1.47% C: 0.9%
GLTO | $0.681 7.2K

| -74.91% | O: -1.11% H: 3.36% C: 1.12%
treatment research market

Global Antiviral Therapies Market Anticipated to Gather $66,016.5 Million and Grow at 3.1% CAGR in the 2020-2027 Forecast Period [208-Pages] | Details by Research Dive
Published: 2023-01-27 (Crawled : 13:20) - prnewswire.com
GLAXF | News | $20.305 630

| 17.34% | O: 1.13% H: 1.57% C: 1.57%
JNJ | News | $148.24 -0.59% 1.6M

| -11.71% | O: -0.21% H: 0.19% C: -0.18%
GSK | News | $40.865 0.68% 320K

| 14.86% | O: -0.03% H: 0.3% C: -0.08%
BMY | $49.28 0.29% 800K

| -32.68% | O: 0.0% H: 0.63% C: -0.74%
ABBV | News | $169.22 0.79% 370K

| 13.9% | O: -0.06% H: 0.25% C: -0.7%
research global antiviral market

Global Prescription Drugs Market Analysis Report 2022: Increasing Number of Chronic Diseases Worldwide will Continue to Fuel Growth - Forecast to 2027
Published: 2023-01-19 (Crawled : 17:00) - prnewswire.com
GLAXF | News | $20.305 630

| 14.7% | O: 0.69% H: 0.0% C: -1.52%
SNYNF | News | $92.7 600K

| -4.71% | O: 1.26% H: 1.19% C: 1.19%
TAK | News | $13.35 -0.08% 230K

| -17.22% | O: -0.31% H: 1.15% C: 0.68%
NVO | News | $127.41 1.72% 750K

| -10.37% | O: 0.13% H: 0.65% C: 0.51%
NVS | News | $98.12 3.15% 1.1M

| 2.83% | O: -0.1% H: 0.31% C: 0.17%
JNJ | News | $148.24 -0.59% 1.6M

| -12.16% | O: -0.43% H: 1.33% C: 0.3%
GSK | News | $40.865 0.68% 320K

| 15.35% | O: 0.17% H: 1.36% C: 1.02%
LLY | News | $739.11 1.06% 320K

| 107.76% | O: 0.1% H: 0.97% C: -0.37%
BMY | $49.28 0.29% 800K

| -31.88% | O: 0.29% H: 2.1% C: 1.94%
ABBV | News | $169.22 0.79% 370K

| 12.53% | O: -0.17% H: 1.07% C: -0.16%
SNY | News | $47.375 0.48% 300K

| -7.0% | O: -0.92% H: 0.0% C: 0.0%
GILD | $67.29 0.51% 730K

| -20.05% | O: 0.51% H: 0.49% C: -0.65%
AMGN | News | $272.245 0.12% 220K

| 2.85% | O: -0.9% H: 0.58% C: 0.01%
global report growth market

Active Pharmaceutical Ingredient Global Market Report 2023: Featuring Teva Pharmaceutical, Bristol-Myers Squibb, Merck
Published: 2023-01-04 (Crawled : 21:00) - prnewswire.com
GLAXF | News | $20.305 630

| 15.6% | O: -1.77% H: 0.75% C: 0.75%
GSK | News | $40.865 0.68% 320K

| 15.87% | O: -1.28% H: 0.35% C: -0.29%
LLY | News | $739.11 1.06% 320K

| 101.41% | O: -0.59% H: 0.15% C: -0.56%
BMY | $49.28 0.29% 800K

| -32.33% | O: -1.21% H: 0.89% C: 0.25%
ABBV | News | $169.22 0.79% 370K

| 2.57% | O: -0.37% H: 0.86% C: 0.25%
SNY | News | $47.375 0.48% 300K

| -6.04% | O: -3.07% H: 0.0% C: 0.0%
global active report teva market

← Previous
1
2
3
4
Next →

Gainers vs Losers

89%

11%

Top 10 Gainers

MTTR | News M | $4.65 167.24% 9.8M

AGBA | $2.46 96.8% 28M

Finance

EDBL | News | $6.94 84.57% 1.4M

CZOO | $7.74 55.11% 2.7M

VNRX | $0.84 40.0% 2.6M

ZAPP | $6.02 35.59% 95K

OPRT | News | $3.01 33.78% 6.8M

Finance

MLEC | $1.81 29.29% 2M

MTC | $2.0 28.21% 1.7M

Technology Services

PEGY | $0.0586 27.95% 130M